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A 43-year-old man with a 20 pack-year history of 
smoking presented with chest pain and hemoptysis 
that began one month previously. Chest computed 
tomography (CT) confirmed a 5-cm mass in the 
right upper lobe involving the right hilum with 
occlusion of the right main stem bronchus with ip-
silateral mediastinal lymph node enlargement (Fig. 
1A). The primary tumor extended into the medi-
astinum, but there was no external compression 
of the carina. The patient was diagnosed as having 
stage IIIB non-small cell lung cancer. He received 
concurrent chemo-radiotherapy with cisplatin and 
etoposide and 60 Gy of radiation to the primary 
tumor. The dose distribution was calculated based 
on the CT image, and three-dimensional irradia-
tion was performed. However, the tumor invaded 
the superior vena cava (SVC); hence, irradiation 
of the SVC was unavoidable. Fluoro-deoxyglu-
cose-positron emission tomography (FDG-PET)/ 
/CT scan performed three months after treatment 
completion demonstrated complete response to the 
chemo-radiotherapy. FDG-PET/CT also showed no 
uptake at a radiation fibrosis near the SVC. At 48 
months of follow-up, the patient presented with 
progressive facial and neck swelling. FDG-PET/CT 
scan showed pinpoint narrowing of the SVC. As 
the radiation fibrotic lesion near the SVC did not 
enlarge or present FDG uptake (Fig. 1B), SVC syn-
drome was evaluated not by recurrence of lung can-
cer but by the fibrotic lesion. Stent placement in the 
SVC and anticoagulation with warfarin was initi-
ated. SVC syndrome was controlled by replacement 
and development of collateral circulation. Since 
pleural disseminated lesions were found in the CT 
scan at that time, the disseminated lesions were 
treated with irradiation, subsequent chemotherapy 
and immune checkpoint inhibitors. Thereafter, we 
conducted FDG-PET/CT scans six times every six 
months, but the radiation fibrotic lesion near the 
SVC did not enlarge or present FDG uptake. Two 
years after the onset of SVC syndrome, the lesion 
near the SVC had not enlarged and presented no 
FDG uptake in the FDG-PET/CT scan (Fig. 1C). 
The patient died of meningeal carcinomatosis that 
developed 7 years after the initial chemo-radiother-
apy. Autopsy examination was not performed.
The majority of patients with SVC syndrome 
are those with cancer-related SVC syndrome [1]. 
Embolism associated with a tumor should also be 
included in the differential diagnosis of SVC syn-
drome in cancer patients [1]. Radiation fibrotic le-
sions have also been attributed to the activation 
and proliferation of fibroblasts that secrete unor-
ganized extracellular matrix. Transforming growth 
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factor-beta (TGF-β) is evaluated as one of the key 
cytokines for the initiation as well as proliferation 
of radiation fibrotic lesions [3]. TGF-β leads to the 
recruitment and activation of fibroblasts. Its release 
by platelets and myoblasts after irradiation leads 
to a vicious cycle of fibrosis [2]. Patients with SVC 
syndrome due to fibrotic lesions formed by irradia-
tion have been very rare [4–9]. A PubMed search 
revealed six such patients [4–9]. Two of them de-
veloped SVC syndrome after chemoradiotherapy 
[8, 9]. FDG-PET/CT was performed in two of the 
other four patients. In them, FDG uptake was not 
observed in the radiation fibrotic lesion formed 
at the irradiation site. That result was consistent 
with ours. The follow-up period for these two pa-
tients was nine months and one year after the onset 
of SVC syndrome, respectively. Our patient was 
followed up for five years, during which several 
FDG-PET examinations confirmed that there was 
no FDG uptake in the radiation fibrotic lesion. 
None of the other described patients had several 
PDG-PET imaging tests as our patient had. The 
follow-up period of the four patients since onset of 
SVC syndrome was between six months and three 
years. In our patient, the follow-up period since 
onset of SVC syndrome was five years. Five of the 
encountered patients had information available re-
garding their treatment for SVC syndrome. Among 
them, three patients had surgical bypass grafting of 
the SVC, one patient had a stent inserted, and one 
patient received only anticoagulation with warfarin. 
SVC surgical bypass transplant is often performed 
for SVC syndrome due to non-malignant causes 
because of a lower rate of re-occlusion in these 
patients [10]. Our patient underwent stenting and 
was given warfarin but did not develop thrombo-
embolism. His treatment was determined and im-
plemented in consideration of the patient’s general 
condition, local and systemic cancer control status, 
and life expectancy. 
In conclusion, in patients with SVC in the irra-
diation field, an FDG-PET/CT scan might be useful 
to determine whether the SVC syndrome is due to 
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Figure 1. Chest computed tomography (Ct) at admission showed an enlargement of mediastinal lymph node on the right 
(A). Fluoro-deoxyglucose-positron emission tomography (FdG-Pet)/Ct scan taken at the time of development of superior 
vena cava syndrome which showed no enlargement or uptake at the radiation fibrotic lesion near the superior vena cava (B). 
FGd-Pet/Ct scan taken two years after the development of superior vena cava (SVC) syndrome. the lesion near the SVC did 
not enlarge or had no FdG uptake (C)
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